BAREing it all: The adoption of LXR and FXR and their roles in lipid homeostasis

Journal of Lipid Research

Volumn 43, Issue 1, 2002, Pages 2-12

  Edwards, Peter A ^a,b   Kast, Heidi R ^a   Anisfeld, Andrew M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ABC transporters; Bile acids; Farnesoid X activated receptor; Lipoproteins; Liver X activated receptor; Oxysterols; Pregnane X receptor; Sitosterolemia; Tangier disease

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL; FARNESOID X RECEPTOR; FATTY ACID; LIPOPROTEIN; LIVER X ACTIVATED RECEPTOR; PREGNANE X RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

BILE ACID METABOLISM; CHOLESTEROL METABOLISM; DRUG DESIGN; DRUG METABOLISM; DRUG TARGETING; FATTY ACID METABOLISM; GENE ACTIVATION; GENE CONTROL; HORMONE RESPONSIVE ELEMENT; HUMAN; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MEDICAL LITERATURE; NONHUMAN; PRIORITY JOURNAL; PUBLICATION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION;

ANIMALS; BILE ACIDS AND SALTS; CHOLESTEROL; DNA-BINDING PROTEINS; HOMEOSTASIS; HUMANS; LIPOPROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TRANSCRIPTION FACTORS;

EID: 0036164154     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. The nuclear receptor superfamily: The second decade
2. The RXR heterodimers and orphan receptors
3. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers
4. The coregulator exchange in transcriptional functions of nuclear receptors
5. Coregulator codes of transcriptional regulation by nuclear receptors
6. The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism
7. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
8. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha
9. Bile acids: Natural ligands for an orphan nuclear receptor
10. Identification of a nuclear receptor for bile acids
11. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
12. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
13. An essential role for nuclear receptors SXR/RXR in detoxification of cholestatic bile acids
14. LXR, a nuclear receptor that defines a distinct retinoid response pathway
15. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
16. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta
17. Role of LXRs in control of lipogenesis
18. Identification of a nuclear receptor that is activated by farnesol metabolites
19. Isolation of proteins that interact specifically with the retinoid X receptor: Two novel orphan receptors
20. Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway
21. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer
22. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor
23. Regulation of multidrug resistance-associated protein 2 (MRP2; ABCC2) by the nuclear receptors PXR, FXR, and CAR
24. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor
25. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor
26. Orphan nuclear receptors: Shifting endocrinology into reverse
27. Orphan nuclear receptors: The exotics of xenobiotics
28. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
29. SXR, a novel steroid and xenobiotic-sensing nuclear receptor
30. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
31. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
32. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
33. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module
34. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
35. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
36. Molecular medicine. The cholesterol quartet
37. Two genes that map to the STSL locus cause sitosterolemia: Genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
38. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
39. Dietary cholesterol absorption: More than just bile
40. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
41. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
42. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
43. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
44. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice
45. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency
46. TP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism
47. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha
48. Nuclear orphan receptors control cholesterol catabolism
49. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
50. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice
51. Catalysis of ACAT may be completed within the plane of the membrane: A working hypothesis
52. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter
53. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands
54. Regulation of gene expression by SREBP and SCAP
55. CTP:phosphocholine cytidylyltransferase, a new sterol and SREBP-responsive gene
56. Sterol regulatory element-binding proteins (SREBPs): Key regulators of nutritional homeostasis and insulin action
57. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
58. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
59. CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene
60. Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription
61. Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase
62. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
63. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
64. Identification of a sister gene to P-glycoprotein
65. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
66. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
67. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
68. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver
69. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin
70. Humanized xenobiotic response in mice expressing nuclear receptor SXR
71. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha
72. ABC1 gene expression and apoA-I-mediated cholesterol efflux are regulated by LXR
73. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
74. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
75. LXR regulation of the LXRa gene in human macrophages
76. Autoregulation of the human LXRa promoter
77. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
78. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha
79. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
80. Regulation and intracellular trafficking of the ABCA1 transporter
81. ABCA1: The gatekeeper for eliminating excess tissue cholesterol
82. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
83. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter
84. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
85. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
86. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein
87. Preferential ATP-binding cassette transporter A1 (ABCA1)-mediated cholesterol efflux from late endosomes/lysosomes
88. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts
89. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
90. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
91. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages
92. Characterization of the human ABCG1 Gene: LXR activates an internal promoter that produces a novel transcript encoding an alternative form of the protein
93. Genomic sequence and structure of the human ABCG1 (ABC8) gene
94. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
95. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta
96. Activated FXR induces apoC-II transcription: A molecular mechanism linking plasma triglyceride levels to bile acids
97. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
98. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
99. Evolutionary duplication of a hepatic control region in the human apolipoprotein E gene locus. Identification of a second region that confers high level and liver-specific expression of the human apolipoprotein E gene in transgenic mice
100. Two hepatic enhancers, HCR.1 and HCR.2, coordinate the liver expression of the entire human apolipoprotein E/C-I/C-IV/C-II gene cluster
101. Identification of a chemical tool for the orphan nuclear receptor FXR